Attention-deficit/hyperactivity disorder: current aspects on pharmacogenetics.
Rohde
L A
LA
ADHD Outpatient Clinic, Child and Adolescent Psychiatric Division, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil. lrohde@terra.com.br
Roman
T
T
Hutz
M H
MH
D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy* / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics; D050483:Dopamine Plasma Membrane Transport Proteins; D006801:Humans; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D008774:Methylphenidate / Q000627:therapeutic use; D009419:Nerve Tissue Proteins; D010597:Pharmacogenetics / Q000379:methods* / Q000639:trends*; D029701:Saccharomyces cerevisiae Proteins
C060858:DAT1 protein, S cerevisiae; D004268:DNA-Binding Proteins; D050483:Dopamine Plasma Membrane Transport Proteins; D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D029701:Saccharomyces cerevisiae Proteins; D008774:Methylphenidate